Breaking News: Americold Boosts Sustainability Efforts with Expanded Credit Facilities

Americold Announces Upsizing and Extension of New Sustainability-Linked Senior Unsecured Credit Facilities ATLANTA, GA., Aug. 24, 2022 (GLOBE NEWSWIRE) — Americold Realty Trust, Inc. (NYSE: COLD) Americold, the world’s largest publicly traded REIT focused on temperature-controlled warehouses, has made an exciting announcement. The company has extended and upsized its senior unsecured credit facilities from $1.5…

Read More

Silver Short-Term Forecast: A Follow-Up and Update (Because We’re All Just Trying to Predict the Future, Right?)

Hi Traders! Silver Short Term Forecast Follow Up And Update Recap Of Previous Forecast On July 28th, I shared a “Silver Short Term Forecast And Technical Analysis” post in our blog. In that post, we discussed the setup and analyzed how it could potentially develop. If you’re interested in learning more about our trading strategies…

Read More

Collaboration between Vivun and Presales Collective to Revolutionize the Future of Presales

Collaboration between Vivun and Presales Collective to Revolutionize the Future of Presales Joint Manifesto Offers New Title and Organizational Structure for the Profession OAKLAND, Calif., Aug. 24, 2022 (GLOBE NEWSWIRE) — Vivun and PreSales Collective have joined forces to rethink the future of the PreSales profession In an industry-first collaboration, Vivun and PreSales Collective are…

Read More

Attention Investors: Don’t Miss the Deadline for MissFresh Limited’s MF IPO – Hagens Berman National Trial Attorneys Urges You to Act Now!

Investor Alert: Missfresh Limited (NASDAQ: MF) Act Now to Protect Your Investments San Francisco, Aug. 24, 2022 (GLOBE NEWSWIRE) – Hagens Berman Urges Missfresh Investors If you are an investor who purchased American Depositary Shares in Missfresh Limited’s initial public offering on June 25, 2021, and have experienced significant losses, it is crucial that you…

Read More

Unleashing the Power of GFH009: A Promising CDK9 Inhibitor for Neuroendocrine Prostate Cancer Treatment – A Preclinical Study

Neuroendocrine Prostate Cancer: An Unmet Medical Need Solving the Puzzle with SELLAS Life Sciences Breaking Down the Latest News SELLAS Life Sciences Group, Inc. has recently announced groundbreaking results from a new preclinical study involving their highly selective CDK9 inhibitor, GFH009. This inhibitor has demonstrated significant potential in inhibiting cancer cell growth in preclinical models,…

Read More

Neuroscience Breakthrough: Brain Scientific’s NeuroCap Device Receives CE Mark Approval!

Welcome to the World of Neurology! Exciting News from Brain Scientific Lakewood Ranch, Florida – August 24, 2022 Hey there, fellow brainiacs! Have you heard the latest buzz in the world of medical technology? Brain Scientific, a cutting-edge medical device technology company based in Florida, just announced some incredibly exciting news. They have officially received…

Read More

Revolutionizing Recruitment: How Cutting-Edge Tech is Making Patient Enrollment a Breeze!

Welcome to the World of Patient Engagement! A New Era in Healthcare Technology Science 37 Enhances Patient Recruitment and Enrollment Hey there, fellow health enthusiasts! Have you heard the latest news about Science 37 Holdings, Inc.? They have just unveiled groundbreaking patient relationship management and contact center technology that is set to revolutionize patient engagement…

Read More